PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,753,000 | -13.6% | 2,455,900 | -21.8% | 0.17% | -12.6% |
| Q2 2018 | $15,920,000 | -57.9% | 3,140,000 | -43.4% | 0.19% | -59.5% |
| Q1 2018 | $37,851,000 | -30.9% | 5,550,000 | -23.5% | 0.47% | -32.3% |
| Q4 2017 | $54,810,000 | +31.1% | 7,259,620 | 0.0% | 0.69% | +73.2% |
| Q3 2017 | $41,815,000 | +13.8% | 7,259,620 | 0.0% | 0.40% | +3.9% |
| Q2 2017 | $36,734,000 | +94.6% | 7,259,620 | 0.0% | 0.38% | +79.9% |
| Q1 2017 | $18,875,000 | +85.0% | 7,259,620 | 0.0% | 0.21% | +64.6% |
| Q4 2016 | $10,201,000 | -23.1% | 7,259,620 | 0.0% | 0.13% | -13.9% |
| Q3 2016 | $13,267,000 | +13.5% | 7,259,620 | 0.0% | 0.15% | +23.8% |
| Q2 2016 | $11,688,000 | -15.3% | 7,259,620 | 0.0% | 0.12% | -15.9% |
| Q1 2016 | $13,793,000 | -17.0% | 7,259,620 | 0.0% | 0.14% | -4.0% |
| Q4 2015 | $16,625,000 | +25.1% | 7,259,620 | 0.0% | 0.15% | +12.7% |
| Q3 2015 | $13,285,000 | -33.5% | 7,259,620 | 0.0% | 0.13% | -8.2% |
| Q2 2015 | $19,964,000 | – | 7,259,620 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |